Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells

Xiang Fang, M. VanRollins, T. L. Kaduce, A. A. Spector

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs) are eicosanoids synthesized from arachidonic acid by the cytochrome P450 epoxygenase pathway. The present studies demonstrate that 8,9-, 11.12-, and 14,15-EET are rapidly taken up by porcine aortic smooth muscle cells. About half of the uptake is incorporated into phospholipids, and saponification indicates that most of this remains in the form of EET. The EETs also are converted to the corresponding dihydroxyeicosatrienoic acids (DHETs) and during prolonged incubations, additional metabolites that do not retain the EET carboxyl groups are formed. Most of these products are released into the medium. However, some DHET and metabolites less polar than EET are incorporated into the phospholipids, and a small amount of unesterified EET is also present in the cells. The incorporation of 14,15-EET and its conversion to DHET did not approach saturation until the concentration exceeded 10-20 μM, indicating that vascular smooth muscle has a large capacity to utilize this EET. These findings suggest that certain vasoactive effects of EETs may be due to their incorporation by smooth muscle cells. Furthermore, through conversion to DHET and other oxidized metabolites, smooth muscle apparently has the capacity to inactive EETs that are either formed in or penetrate into the vascular wall.

Original languageEnglish (US)
Pages (from-to)1236-1246
Number of pages11
JournalJournal of Lipid Research
Volume36
Issue number6
StatePublished - 1995
Externally publishedYes

Fingerprint

Metabolism
Smooth Muscle Myocytes
Muscle
Phospholipids
Metabolites
Cells
Acids
Eicosanoids
Vascular Smooth Muscle
Arachidonic Acid
Cytochrome P-450 Enzyme System
Smooth Muscle
Blood Vessels
Swine
Saponification
14,15-epoxy-5,8,11-eicosatrienoic acid
8,9-epoxyeicosatrienoic acid

Keywords

  • arachidonic acid
  • dihydroxyeicosatrienoic acid
  • eicosanoids
  • epoxides
  • phospholipids

ASJC Scopus subject areas

  • Endocrinology

Cite this

Fang, X., VanRollins, M., Kaduce, T. L., & Spector, A. A. (1995). Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. Journal of Lipid Research, 36(6), 1236-1246.

Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. / Fang, Xiang; VanRollins, M.; Kaduce, T. L.; Spector, A. A.

In: Journal of Lipid Research, Vol. 36, No. 6, 1995, p. 1236-1246.

Research output: Contribution to journalArticle

Fang, X, VanRollins, M, Kaduce, TL & Spector, AA 1995, 'Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells', Journal of Lipid Research, vol. 36, no. 6, pp. 1236-1246.
Fang, Xiang ; VanRollins, M. ; Kaduce, T. L. ; Spector, A. A. / Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. In: Journal of Lipid Research. 1995 ; Vol. 36, No. 6. pp. 1236-1246.
@article{f89e1f850ddd403da03421b05d4a3405,
title = "Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells",
abstract = "Epoxyeicosatrienoic acids (EETs) are eicosanoids synthesized from arachidonic acid by the cytochrome P450 epoxygenase pathway. The present studies demonstrate that 8,9-, 11.12-, and 14,15-EET are rapidly taken up by porcine aortic smooth muscle cells. About half of the uptake is incorporated into phospholipids, and saponification indicates that most of this remains in the form of EET. The EETs also are converted to the corresponding dihydroxyeicosatrienoic acids (DHETs) and during prolonged incubations, additional metabolites that do not retain the EET carboxyl groups are formed. Most of these products are released into the medium. However, some DHET and metabolites less polar than EET are incorporated into the phospholipids, and a small amount of unesterified EET is also present in the cells. The incorporation of 14,15-EET and its conversion to DHET did not approach saturation until the concentration exceeded 10-20 μM, indicating that vascular smooth muscle has a large capacity to utilize this EET. These findings suggest that certain vasoactive effects of EETs may be due to their incorporation by smooth muscle cells. Furthermore, through conversion to DHET and other oxidized metabolites, smooth muscle apparently has the capacity to inactive EETs that are either formed in or penetrate into the vascular wall.",
keywords = "arachidonic acid, dihydroxyeicosatrienoic acid, eicosanoids, epoxides, phospholipids",
author = "Xiang Fang and M. VanRollins and Kaduce, {T. L.} and Spector, {A. A.}",
year = "1995",
language = "English (US)",
volume = "36",
pages = "1236--1246",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells

AU - Fang, Xiang

AU - VanRollins, M.

AU - Kaduce, T. L.

AU - Spector, A. A.

PY - 1995

Y1 - 1995

N2 - Epoxyeicosatrienoic acids (EETs) are eicosanoids synthesized from arachidonic acid by the cytochrome P450 epoxygenase pathway. The present studies demonstrate that 8,9-, 11.12-, and 14,15-EET are rapidly taken up by porcine aortic smooth muscle cells. About half of the uptake is incorporated into phospholipids, and saponification indicates that most of this remains in the form of EET. The EETs also are converted to the corresponding dihydroxyeicosatrienoic acids (DHETs) and during prolonged incubations, additional metabolites that do not retain the EET carboxyl groups are formed. Most of these products are released into the medium. However, some DHET and metabolites less polar than EET are incorporated into the phospholipids, and a small amount of unesterified EET is also present in the cells. The incorporation of 14,15-EET and its conversion to DHET did not approach saturation until the concentration exceeded 10-20 μM, indicating that vascular smooth muscle has a large capacity to utilize this EET. These findings suggest that certain vasoactive effects of EETs may be due to their incorporation by smooth muscle cells. Furthermore, through conversion to DHET and other oxidized metabolites, smooth muscle apparently has the capacity to inactive EETs that are either formed in or penetrate into the vascular wall.

AB - Epoxyeicosatrienoic acids (EETs) are eicosanoids synthesized from arachidonic acid by the cytochrome P450 epoxygenase pathway. The present studies demonstrate that 8,9-, 11.12-, and 14,15-EET are rapidly taken up by porcine aortic smooth muscle cells. About half of the uptake is incorporated into phospholipids, and saponification indicates that most of this remains in the form of EET. The EETs also are converted to the corresponding dihydroxyeicosatrienoic acids (DHETs) and during prolonged incubations, additional metabolites that do not retain the EET carboxyl groups are formed. Most of these products are released into the medium. However, some DHET and metabolites less polar than EET are incorporated into the phospholipids, and a small amount of unesterified EET is also present in the cells. The incorporation of 14,15-EET and its conversion to DHET did not approach saturation until the concentration exceeded 10-20 μM, indicating that vascular smooth muscle has a large capacity to utilize this EET. These findings suggest that certain vasoactive effects of EETs may be due to their incorporation by smooth muscle cells. Furthermore, through conversion to DHET and other oxidized metabolites, smooth muscle apparently has the capacity to inactive EETs that are either formed in or penetrate into the vascular wall.

KW - arachidonic acid

KW - dihydroxyeicosatrienoic acid

KW - eicosanoids

KW - epoxides

KW - phospholipids

UR - http://www.scopus.com/inward/record.url?scp=0029070361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029070361&partnerID=8YFLogxK

M3 - Article

C2 - 7666001

AN - SCOPUS:0029070361

VL - 36

SP - 1236

EP - 1246

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 6

ER -